Cite
HARVARD Citation
Rosmarin, D. et al. (2022). Rapid Improvement in Skin Pain Severity and Its Impact on Quality of Life in Adult Patients With Moderate-to-Severe Atopic Dermatitis From a Double-Blind, Placebo-Controlled Baricitinib Phase 3 Study. Journal of cutaneous medicine and surgery. 26 (4), pp. 377-385. [Online].